Haemonetics reported $145.79M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 844.2M 268.3M Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Globus Medical USD 585.49M 250.09M Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
ICU Medical USD 501.85M 10.59M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Quidel USD 606.8M 39.4M Sep/2026
ResMed USD 1.01B 83.57M Jun/2026
STAAR Surgical USD 77.95M 5.48M Sep/2026
Steris USD 1.27B 62.5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 3.49B 589.18M Sep/2026
Terumo JPY 331.37B 109.04B Sep/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
US Physical Therapy USD 197.6M 5.49M Sep/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026